Affiliations 

  • 1 Cryogonia Cryopreservation Bank, Athens, Greece
  • 2 Department of Andrology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, AECR, Tehran, Iran
  • 3 Global Andrology Forum, Morelands Hills, OH, USA
  • 4 Next Fertility GynePro - NextClinics International, Bologna, Italy
  • 5 Global Andrology Forum, Morelands Hills, OH, USA - agarwaa32099@outlook.com
Panminerva Med, 2023 Jun;65(2):135-147.
PMID: 37103485 DOI: 10.23736/S0031-0808.23.04836-X

Abstract

Male infertility is attributed to multiple factors including high levels of sperm DNA fragmentation (SDF). Conventional semen analysis continues to be the gold standard for diagnosis of male factor infertility around the world. However, the limitations of basic semen analysis have prompted the search for complementary assessments of sperm function and integrity. Sperm DNA fragmentation assays (direct or indirect) are emerging as important diagnostic tools in male infertility workups, and have been advocated for use in infertile couples for a variety of reasons. While a controlled degree of DNA nicking is required for appropriate DNA compaction, excessive fragmentation of sperm DNA is linked to impaired male fertility potential, decreased fertilization, poor embryo quality, recurrent pregnancy loss, and failure of assisted reproductive technology procedures. However, there is an ongoing debate regarding whether or not to employ SDF as a routine test for male infertility. This review compiles up-to-date information regarding the pathophysiology of SDF, the currently available SDF tests, and the role of SDF tests in natural and assisted conception conditions.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.